MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40425-019-0534-z

Медицинская библиотека · Journal for immunotherapy of cancer · 2019

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.

Sugano Teppei, Seike Masahiro, Funasaka Yoko, Yoshida Mai, Takayama Ryoko, Okamura Ken, Nakanishi Asuka, Tanaka Toru, Takeuchi Susumu, Noro Rintaro, Minegishi Yuji, Kubota Kaoru, Saeki Hidehisa, Gemma Akihiko

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Pembrolizumab, an anti-programmed cell death-1 protein monoclonal antibody, is effective for patients with advanced non-small-cell lung cancer. However, immune checkpoint inhibitors such as pembrolizumab induce various immune-related adverse events, involving the lung, liver, gastrointestinal, endocrine system, and skin. Intralymphatic histiocytosis (ILH) is a rare, chronic cutaneous disorder with a reactive inflammatory component, which often occurs in patients with rheumatoid arthritis.

CASE PRESENTATION: We present a 67-year-old man with lung adenocarcinoma who developed ILH associated with pembrolizumab treatment. He was treated with palliative thoracic radiotherapy for superior vena cava syndrome. Subsequently, he received four cycles of pembrolizumab. Approximately 2.5 months after the initiation of pembrolizumab, he developed erythema on the trunk of his body. Based on findings of skin biopsies, he was diagnosed with pembrolizumab-induced ILH. Moreover, the upregulation of tumor necrosis factor-α was observed during pembrolizumab therapy.

CONCLUSIONS

This is the first report of ILH induced by pembrolizumab in a patient with lung adenocarcinoma.

Для цитирования: Sugano Teppei, Seike Masahiro, Funasaka Yoko, Yoshida Mai, Takayama Ryoko, Okamura Ken, Nakanishi Asuka, Tanaka Toru, Takeuchi Susumu, Noro Rintaro, Minegishi Yuji, Kubota Kaoru, Saeki Hidehisa, Gemma Akihiko. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.. Journal for immunotherapy of cancer. 2019. DOI: 10.1186/s40425-019-0534-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.